News

UroGen outlines $5B market opportunity as UGN-102 FDA review nears and commercial launch preparations accelerate
Q1 2025 Management View Liz Barrett, President and Chief Executive Officer, highlighted that "the new drug application for ...
Trump signs executive order setting 30-day deadline for drugmakers to lower prescription drug costs
Trump's executive order sets a deadline for drugmakers to lower the cost of prescription drugs in the U.S. or face new limits ...
JD Supra46m
FDA Identifies Data Quality and Study Conduct Concerns With Raptim Research and Requires Sponsors to Submit Replacement Study Data
The Food and Drug Administration (FDA) recently announced that it had identified “significant data integrity and study conduct concerns” ...